The world's first artificial pancreas rollout improved blood sugar control, reduced diabetes burden, and expanded equitable ...

The UK's NHS has reported encouraging results from the first large-scale rollout of artificial pancreas systems for type 1 diabetes. The data also shows the technology reached poorer and minority ...

Adults with type 2 diabetes achieved higher time in range with the next-generation Omnipod 6 automated insulin delivery ...

PODD's Omnipod 5 momentum and global growth support its outlook, but competitive pressure and macro costs may test its margin ...

Now a new generation of devices is trying to do something the read-only wearable never could, talk back to the body.

I am a physician with good insurance, but every year we have faced higher out-of-pocket cost for my son’s EpiPen.

Pomerantz LLP announces that a class action lawsuit has been filed against Insulet Corporation (“Insulet” or the “Company”) ...

The world's first large-scale artificial pancreas rollout has delivered promising results, helping people with type 1 ...

A read-write wearable both reads your body and writes back to it by delivering an intervention.

Living with type 1 diabetes means navigating an endless mental marathon. Between calculating insulin doses and managing ...

By 2050, scientists estimate that antibiotic-resistant infections will be associated with more than 8 million deaths around ...